1. Home
  2. CMPS vs TMQ Comparison

CMPS vs TMQ Comparison

Compare CMPS & TMQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

HOLD

Current Price

$6.60

Market Cap

662.5M

Sector

Health Care

ML Signal

HOLD

Logo Trilogy Metals Inc.

TMQ

Trilogy Metals Inc.

HOLD

Current Price

$5.70

Market Cap

785.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMPS
TMQ
Founded
2020
2004
Country
United Kingdom
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Precious Metals
Sector
Health Care
Basic Materials
Exchange
Nasdaq
Nasdaq
Market Cap
662.5M
785.2M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
CMPS
TMQ
Price
$6.60
$5.70
Analyst Decision
Strong Buy
Analyst Count
8
0
Target Price
$16.86
N/A
AVG Volume (30 Days)
1.4M
6.6M
Earning Date
02-26-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$1.13
52 Week High
$8.20
$11.29

Technical Indicators

Market Signals
Indicator
CMPS
TMQ
Relative Strength Index (RSI) 44.99 52.42
Support Level $6.49 $4.93
Resistance Level $7.45 $7.25
Average True Range (ATR) 0.40 0.60
MACD -0.11 -0.10
Stochastic Oscillator 15.02 31.25

Price Performance

Historical Comparison
CMPS
TMQ

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About TMQ Trilogy Metals Inc.

Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.

Share on Social Networks: